Ying Wei Selected Research

Airway Remodeling

10/2022	A novel iridoid glycoside leonuride (ajugol) attenuates airway inflammation and remodeling through inhibiting type-2 high cytokine/chemokine activity in OVA-induced asthmatic mice.
1/2021	RNA-Seq Expression Analysis of Chronic Asthmatic Mice with Bu-Shen-Yi-Qi Formula Treatment and Prediction of Regulated Gene Targets of Anti-Airway Remodeling.
4/2019	Bu-Shen-Yi-Qi formula ameliorates airway remodeling in murine chronic asthma by modulating airway inflammation and oxidative stress in the lung.
1/2018	Scutellaria baicalensis Attenuates Airway Remodeling via PI3K/Akt/NF-κB Pathway in Cigarette Smoke Mediated-COPD Rats Model.
1/2013	Recombinant rat CC10 protein inhibits PDGF-induced airway smooth muscle cells proliferation and migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Wei Research Topics

Disease

50	Neoplasms (Cancer) 05/2024 - 01/2003
47	Inflammation (Inflammations) 09/2023 - 01/2011
37	Asthma (Bronchial Asthma) 09/2023 - 07/2010
16	Infections 10/2023 - 04/2005
16	Neoplasm Metastasis (Metastasis) 03/2023 - 01/2003
15	Stroke (Strokes) 04/2024 - 02/2009
12	Fibrosis (Cirrhosis) 12/2023 - 01/2009
12	Respiratory Hypersensitivity 10/2022 - 01/2014
11	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2019
9	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2024 - 01/2011
9	Lung Neoplasms (Lung Cancer) 03/2023 - 11/2008
8	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2024 - 01/2009
8	Pneumonia (Pneumonitis) 02/2023 - 01/2014
7	Infarction (Infarctions) 04/2024 - 01/2011
7	Ischemic Stroke 01/2024 - 09/2010
7	Body Weight (Weight, Body) 10/2022 - 01/2015
6	COVID-19 11/2023 - 10/2020
6	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 01/2011
6	Insulin Resistance 01/2021 - 01/2017
6	Ischemia 10/2019 - 01/2011
5	Airway Remodeling 10/2022 - 01/2013
5	Necrosis 03/2022 - 01/2015
5	Hypoxia (Hypoxemia) 01/2022 - 01/2012
5	Brain Ischemia (Cerebral Ischemia) 01/2022 - 09/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2015
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2011
5	Human Influenza (Influenza) 12/2017 - 07/2015
4	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2012
4	Myocardial Infarction 04/2024 - 08/2011
4	Reperfusion Injury 04/2024 - 01/2011
4	Cognitive Dysfunction 01/2024 - 01/2022
4	Periodontitis 10/2023 - 10/2021
4	Atrial Fibrillation 09/2023 - 01/2020
4	Hyperplasia 09/2023 - 06/2015
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2016
4	Hypertension (High Blood Pressure) 10/2018 - 05/2012
3	Schizophrenia (Dementia Praecox) 01/2024 - 09/2022
3	Non-alcoholic Fatty Liver Disease 10/2023 - 11/2011
3	Atrial Remodeling 09/2023 - 01/2020
3	Hypersensitivity (Allergy) 01/2023 - 05/2021
3	Papillary Thyroid Cancer 01/2023 - 01/2021
3	Obstructive Sleep Apnea 01/2023 - 01/2016
3	Thyroid Nodule (Nodule, Thyroid) 01/2023 - 10/2016
3	Hyperuricemia 12/2022 - 11/2017
3	Liver Neoplasms (Liver Cancer) 11/2022 - 04/2017

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2009
18	OvalbuminIBA 09/2023 - 01/2015
15	CytokinesIBA 12/2023 - 08/2008
15	Biomarkers (Surrogate Marker)IBA 12/2023 - 08/2012
13	CollagenIBA 12/2023 - 10/2017
8	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2011
8	Therapeutic UsesIBA 12/2023 - 01/2011
8	RNA (Ribonucleic Acid)IBA 08/2023 - 01/2018
8	LipidsIBA 07/2022 - 11/2011
7	Bleomycin (Blenoxane)FDA LinkGeneric 05/2024 - 01/2009
7	Messenger RNA (mRNA)IBA 12/2023 - 01/2011
7	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2011
7	Interleukin-4 (Interleukin 4)IBA 02/2023 - 01/2014
7	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 01/2014
7	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2014
6	Eosine Yellowish-(YS) (Eosin)IBA 07/2023 - 02/2013
6	Hematoxylin (Haematoxylon)IBA 07/2023 - 02/2013
6	Interleukin-13IBA 02/2023 - 04/2019
6	Complement System Proteins (Complement)IBA 01/2023 - 01/2014
6	Peptides (Polypeptides)IBA 06/2022 - 11/2008
6	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2014
6	IntegrinsIBA 01/2014 - 01/2003
5	EnzymesIBA 12/2022 - 03/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 11/2011
5	Immunoglobulin E (IgE)IBA 10/2022 - 01/2015
5	Long Noncoding RNAIBA 01/2022 - 02/2020
5	LigandsIBA 01/2020 - 11/2008
5	Urokinase Plasminogen Activator ReceptorsIBA 01/2014 - 01/2005
4	CateninsIBA 05/2024 - 02/2012
4	InterleukinsIBA 12/2023 - 10/2018
4	Phosphotransferases (Kinase)IBA 03/2023 - 10/2017
4	ChemokinesIBA 10/2022 - 09/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 03/2012
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2016
4	CalciumIBA 01/2022 - 01/2019
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2009
3	Ketamine FDA LinkGeneric 01/2024 - 09/2022
3	AntioxidantsIBA 01/2024 - 04/2019
3	Insulin (Novolin)FDA Link 01/2024 - 02/2014
3	icariinIBA 12/2023 - 06/2015
3	ORALIT (ORS)IBA 10/2023 - 01/2019
3	InflammasomesIBA 06/2023 - 01/2021
3	Estrogens (Estrogen)FDA Link 01/2023 - 09/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 04/2005
3	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2020
3	AllergensIBA 01/2023 - 12/2020
3	VaccinesIBA 10/2022 - 07/2015
3	OligopeptidesIBA 10/2022 - 12/2019

Therapy/Procedure

34	Therapeutics 01/2024 - 08/2008
10	Drug Therapy (Chemotherapy) 04/2024 - 08/2008
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2014
5	Acupuncture Therapy 02/2023 - 01/2015
3	Intraperitoneal Injections 11/2022 - 11/2016
3	Oral Administration 10/2022 - 04/2015